Hyperthermic intraperitoneal chemotherapy (HIPEC) increases risk of local anesthetic systemic toxicity (LAST)
Saved in:
Main Authors: | Masahiko Tsuchiya, Hiroharu Takesada, Koh Mizutani |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-01-01
|
Series: | Saudi Journal of Anaesthesia |
Online Access: | https://journals.lww.com/10.4103/sja.sja_481_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single center experience with Hypotension Prediction Index (HPI) during cytoreductive surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
by: Camilla L’Acqua, et al.
Published: (2025-01-01) -
Hyperthermic intraperitoneal chemotherapy: Ideal and reality
by: Fan-He Dong, et al.
Published: (2025-02-01) -
Preliminary Results of Hyperthermic Intraperitoneal Intraoperative Chemotherapy as an Adjuvant in Resectable Pancreatic Cancer
by: Antonios-Apostolos K. Tentes, et al.
Published: (2012-01-01) -
Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients
by: Lana Bijelic, et al.
Published: (2012-01-01) -
Laparoscopic Diagnosis and Laparoscopic Hyperthermic Intraoperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Detected by CT Examination
by: Masamitsu Hirano, et al.
Published: (2012-01-01)